Defiance Leveraged Long + Income MSTR ETFMST

The MST ETF (Defiance concentrated Long + Income MSTR ETF) has seen its assets under management (AUM) stagnate near $150 million, raising questions about liquidity in a fund designed for daily turnover. The ETF, which tracks the Nasdaq-100 Ex-Software Index via derivatives, charges an expense ratio of 0.95%, among the highest in its category. Defiance ETFs’ official materials highlight its "innovative" approach, but filings reveal a concentrated portfolio where the top three holdings-Apple, Microsoft, and Amazon-comprise over 30% of assets. (source: Defiance ETFs Official Fund Centre, https://www.defianceetfs.com/)

The fund’s mandate to provide "concentrated long exposure with income" hinges on a daily rebalancing mechanism that amplifies volatility. SEC filings note that a 1% daily move in the underlying index could result in a 2% swing in the ETF’s net asset value (NAV), before fees. This structure, combined with a dividend strategy that reinvests payouts to boost leverage, creates a compounding effect that benefits the issuer more than long-term holders. (source: SEC EDGAR Fund Search for MST, https://www.sec.gov/edgar/search/#/q=MST)

Recent performance has underscored the risks: in June 2026, the ETF posted a 12% drawdown during a 5% Nasdaq correction, exceeding its 2x leverage target due to tracking error. The fund’s prospectus discloses that such deviations are common during periods of high volatility, though its marketing materials omit this nuance. Liquidity remains a concern, with average daily trading volume under $10 million, limiting exit options during sharp moves. (source: Nasdaq ETF Listing, https://www.nasdaq.com/market-activity/etf/mst)

FINRA’s Fund Analyzer flags the MST ETF as having a "high" expense ratio relative to peers, with a 5-year projected cost of $4,750 on a $10,000 investment. The tool also notes the fund’s use of synthetic derivatives, which introduce counterparty risk absent in physically held ETFs. Defiance ETFs’ FAQ section dismisses such concerns, stating that "derivatives are standard in concentrated products," though it provides no historical performance data to support this claim. (source: FINRA Fund Analyzer, https://tools.finra.org/fund_analyzer/)